BIOVERSYS AG

We develop small chemical molecules, which switch off drug resistance on a gene regulatory level within bacteria, so called TRIC’s (Transcriptional Regulator Inhibitory Compounds). Current pipeline: Gram negative and positive bacteria; Tuberculosis.

BioVersys AG
Technologiepark Basel
Hochbergerstrasse 60C
4057 Basel

Tel:+41 61 633 22 50  
Fax: +41 61 633 22 59

email


company website

testimonial about Technologiepark Basel

The Technologiepark Basel is a perfect working environment for Start Ups, combining great infrastructure, a great location in Basel and a collaborative environment to start and grow your business.